Brentuximab Vedotin
ATC L01FX05 · 9 markets · 12 records
AU 3 records · 2 strengths
- 50 mginjectionADCETRISADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial
Records without a stated strength · 1 ADCETRIS
US 1 records · 1 strengths
- 50 mg/10.5 mLinjectionADCETRIS
GB 1 records · 1 strengths
- 50 mginjectionAdcetris 50mg powder for concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 50 mgpowderADCETRIS
SG 1 records · 1 strengths
- 50 mg/vialinjectionADCETRIS® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
ES 1 records · 1 strengths
- 50 mginjectionADCETRIS
TW 1 records · 1 strengths
- 50 mginjectionADCETRIS 50 mg powder for concentrate for solution for infusion雅詩力 凍晶注射劑 50毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 ADCETRIS 50 mg powder for concentrate for solution for infusion
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ADCETRIS
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 50 mg injection | Adcetris 50mg powder for concentrate for solution for infusion vials | ADCETRIS ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial | ADCETRIS | ADCETRIS 50 mg powder for concentrate for solution for infusion 雅詩力 凍晶注射劑 50毫克 | |||||
| 50 mg/10.5 mL injection | ADCETRIS | ||||||||
| 50 mg/vial injection | ADCETRIS® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL | ||||||||
| 50 mg powder | ADCETRIS | ||||||||
unknown | ADCETRIS | ADCETRIS 50 mg powder for concentrate for solution for infusion | ADCETRIS |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA · SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.